It is easy to talk about due diligence in the abstract, but it is much harder to practice what you preach. One of the hardest things about early stage investing is that it is really risky – if you don’t have some suspension of disbelief, and you obsess too much about cataloging every risk, you will never get a deal done. As a way of wrapping up this series of articles with a review, let’s take a look at a few common mistakes and see what we can learn from them.
- Takes a Licking and Keeps on Ticking
- Ventura County firefighters make history with in-the-field blood transfusions
- FireRescue1’s “3 Things We’re Watching at FDIC 2025
- Delta Ice 1L debut at New Castle Blood Symposium
- The next evolution in Prehostial Blood Management
- iQure Pharma Receives Approval for iq007 Activity
- Tidewater EMS Council Adopts Delta Development Team
- Nuvox Therapeutics MHRA Approval Phase IIb Stroke Trial
- XLR8 Announces 8-day intensive program for scale-ready Businesses
- Interview James Goulka AZ Venture Capital President